These data support the use of sacituzumab plus pembrolizumab as a potential new standard of care,” said Sara Tolaney, MD.

Convolutional neural networks have obtained note-worthy results in various fields of medicine, giving an objective, virtual second opinion to the physicians concerning the presence of disease ...

Changes to the pre-removal risk assessment for the Democratic Republic of Congo Ottawa, July 4, 2025 —Immigration, Refugees and Citizenship Canada (IRCC) is deeply concerned about the current ...